Hotelbuchung
Hotel Registration
Grußwort
Welcome address
Beteiligte Gesellschaften
Societies involved
DOG Information
DOG Information
Eröffnung des Kongresses
Opening Ceremony
Preise
Awards
Ablauf der Tagung 2003
General overview of congress
Lageplan der Räumlichkeiten
Map of Congress Center
Wissenschaftliche Themen
Scientific topics
Symposien
Symposia
Wissenschaftliches Programm
Scientific program
Posterpräsentationen
Poster Presentation
Kurse
Courses
Begleitende Veranstaltungen
Accompanying program
Arbeitssitzungen
Working sessions
Rahmenprogramm
Social program
Allgemeine Informationen
General Information
Autorenindex
Index of Authors
Industrieaussteller
Commercial exhibitors
Sponsoren
Sponsors
Impressum
DOG Homepage
Abstract
Abstract
Cataract Surgery Combined with Intravitreal Injection of Triamcinolone Acetonide
Akkoyun I., Kreissig I., Budde W. M., Degenring R. F.
Universitäts-Augenklinik, Universitätsklinikum Mannheim, Universität Heidelberg, Mannheim
Purpose: To evaluate the clinical course of patients undergoing cataract surgery combined with an intravitreal injection of triamcinolone acetonide.
Method: The noncomparative prospective clinical interventional case series study included all 55 patients (58 eyes) undergoing cataract surgery, and additionally receiving an intravitreal injection of 25 mg of triamcinolone acetonide as treatment of exudative age-related macular degeneration, diffuse diabetic macular oedema, and other intraocular edematous or proliferative diseases. Mean follow-up time was 3.75 ± 3.97 months.
Results: In none of the patients, postoperative infectious endophthalmitis, wound leakage or other corneal wound healing problems, persisting corneal endothelial decompensation, rhegmatogenous retinal detachment, marked postoperative pain, or a clinically significant decentration of the intraocular lens were observed. Secondary ocular hypertension occurred in 21 (36.2%) eyes. Visual acuity increased significantly (p<0.001) from 0.12 ± 0.10 to 0.17 ± 0.15.
Conclusions: The addition of cataract surgery to an intravitreal injection of 25 mg of triamcinolone acetonide, and vice versa, may not increase amount and frequency of side-effects and complications as compared to the sum of complications of the single procedures.
Zurück | Back